Predoctoral Researcher - Lymphangioleiomyomatosis (LAM)
Ref.: 23-221_R_MP
About the research group
Breast cancer
The Lymphangioleiomyomatosis (LAM) research group within the Oncobell program aims to advance disease care through identification of circulating biomarkers and disease vulnerabilities. The research group is interdisciplinary and embraces national and international collaborations towards these aims. The current proposal aims to decipher the relevance of glucocorticoids signaling in LAM origin and progression. The open position will contribute to this overall objective by performing preclinical studies using in vitro and in vivo LAM models.
About the role
- Translational research to uncover the molecular mechanisms of LAM development and progression
- Research using in vitro and in vivo preclinical models
- Research using clinical samples and analysis of biomarkers
Job requirements
Professional experience
Education and training
Technical & soft skills
-
Cell and molecular biology techniques
-
Human genetic analyses and data interpretation
-
Animal research
-
Teamwork, originality, independence and initiative
Languages
We will value, but not required
- At least 2 year of experience as early researcher
- Mouse research expertise
- Communication skills
What do we offer
-
-
Estimated start date: 02/10/2023
-
Contract duration: 1 year
-
Estimated annual gross salary: 17.650 €
-
You will be part of a multicultural team. We have a fun loving and friendly international work environment.
-
Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
-
Possibility to work some days in remote -Teleworking
-
26 working days of holiday per year
-
System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
-
-
Benefits of constant training are offered
-
We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.
Deadline: Please submit your application by 26/09/2023
Data protection notice
In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.
Our institute
IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
Observations
The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).
IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).
